Patient considerations and clinical utility of a fixed dose combination of saxagliptin/metformin in the treatment of type 2 diabetes

INTRODUCTION: Targeting glycated hemoglobin (HbA(1c)) levels below 7.0% is considered a primary goal of diabetes care, given its importance in obtaining a sustained reduction in microvascular, and possibly macrovascular complications. AIM: The aim of this review was to evaluate the clinical utility...

Descripción completa

Detalles Bibliográficos
Autores principales: Derosa, Giuseppe, Maffioli, Pamela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3139534/
https://www.ncbi.nlm.nih.gov/pubmed/21792325
http://dx.doi.org/10.2147/DMSO.S16361

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3139534/
https://www.ncbi.nlm.nih.gov/pubmed/21792325
http://dx.doi.org/10.2147/DMSO.S16361

Ejemplares similares